ISTA Pharmaceuticals, Inc. (ISTA) announced that financial guidance for the full year 2010, projecting net revenue of about $147 to $165 million.
In addition, ISTA anticipates reporting its first profitable year in 2010, with earnings per share for the full year expected to be at least $0.02, excluding any mark-to-market adjustments relating to warrants.
On average, three analysts polled by Thomson Reuters currently expect the company to earn $0.16 per share, on revenues of $147.90 million for fiscal 2010. Analysts estimates typically exclude special items.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.